141 related articles for article (PubMed ID: 24012217)
1. Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Dikkers FG
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24012217
[No Abstract] [Full Text] [Related]
2. Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24021212
[No Abstract] [Full Text] [Related]
3. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
5. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Rivière F; Gille T; Le Tinier JY; Gharbi N; Khalil A; Wislez M; Cadranel J
Scand J Infect Dis; 2011 Feb; 43(2):112-4. PubMed ID: 21039305
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
8. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
9. The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
San Giorgi MR; Tjon Pian Gi RE; Dikkers FG
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1819-20. PubMed ID: 25351501
[No Abstract] [Full Text] [Related]
10. Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Ksiazek J; Prager JD; Sun GH; Wood RE; Arjmand EM
Otolaryngol Head Neck Surg; 2011 Apr; 144(4):639-41. PubMed ID: 21493248
[TBL] [Abstract][Full Text] [Related]
11. Use of cidofovir in recurrent respiratory papillomatosis.
Carifi M
Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2165-6. PubMed ID: 23545883
[No Abstract] [Full Text] [Related]
12. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
13. Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates.
Gáll T; Kis A; Fehér E; Gergely L; Szarka K
Antiviral Res; 2011 Nov; 92(2):356-8. PubMed ID: 21945249
[TBL] [Abstract][Full Text] [Related]
14. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Grasso M; Remacle M; Bachy V; Van Der Vorst S; Lawson G
Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2983-90. PubMed ID: 24756616
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review.
Drejet S; Halum S; Brigger M; Skopelja E; Parker NP
Otolaryngol Head Neck Surg; 2017 Mar; 156(3):435-441. PubMed ID: 28072562
[TBL] [Abstract][Full Text] [Related]
16. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
17. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
18. [Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Pi Sala N; Figueras Suriol A; Ramió Montero E
Farm Hosp; 2017 Jan; 41(n01):132-133. PubMed ID: 28045657
[No Abstract] [Full Text] [Related]
19. Current treatment for laryngeal papillomatosis.
Kendall KA
Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):157-9. PubMed ID: 15167022
[No Abstract] [Full Text] [Related]
20. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
